광동제약
009290KOSPI· 의료용 물질 및 의약품 제조업6,130원-310 (-4.81%)전일 종가 2026-09-18
52주 위치
5,15012,80013%신고가 대비 -52.11%
- 시가총액
- 3,053억
- PER
- 12.14
- PBR
- 0.48
- EPS(TTM)
- 505원
- BPS
- 12,825원
- 배당수익률
- 1.63%
- 자사주비율
- 0.20%
- 결산월
- 12월
알림 만들기관심종목·메모·논지·저널은 로그인하면 사용 가능
| 항목 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| ROE | 4.81% | 4.76% | 6.96% | 7.20% | 3.40% |
| ROA | 2.89% | 2.94% | 3.92% | 3.72% | 1.71% |
| 영업이익률 | 3.36% | 2.67% | 2.78% | 1.83% | 1.87% |
| 순이익률 | 1.91% | 1.87% | 2.60% | 2.55% | 1.29% |
| 매출총이익률 | 20.49% | 19.70% | 19.80% | 18.24% | 18.15% |
| 부채비율 | 67.63% | 70.37% | 83.33% | 89.28% | 85.49% |
| 유동비율 | 180.59% | 171.32% | 145.67% | 155.89% | 136.45% |
| 매출 성장률(YoY) | — | 6.98% | 5.79% | 8.34% | 1.15% |
| 영업이익 성장률(YoY) | — | -14.89% | 10.00% | -28.46% | 3.15% |
| 순이익 성장률(YoY) | — | 4.54% | 47.46% | 6.28% | -49.03% |
| FCF | 311억 | 375억 | -465억 | -879억 | 571억 |
| FCF 마진 | 2.33% | 2.62% | -3.07% | -5.36% | 3.44% |
| CAPEX/매출 | 1.78% | 1.77% | 2.30% | 4.62% | 1.52% |
| 항목 | 2021 3Q | 2021 4Q | 2022 1Q | 2022 2Q | 2022 3Q | 2022 4Q | 2023 1Q | 2023 2Q | 2023 3Q | 2023 4Q | 2024 1Q | 2024 2Q | 2024 3Q | 2024 4Q | 2025 1Q | 2025 2Q | 2025 3Q | 2025 4Q | 2026 1Q | 2026 2Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 1.82% | 1.32% | 1.51% | 0.59% | 1.28% | 1.41% | 2.72% | 1.65% | 1.77% | 1.15% | 3.34% | 0.24% | 1.59% | 2.16% | 0.66% | 0.44% | 1.85% | 0.64% | 0.72% | 0.44% |
| ROA | 1.07% | 0.78% | 0.99% | 0.42% | 0.83% | 0.79% | 1.65% | 0.95% | 0.97% | 0.61% | 1.78% | 0.16% | 0.82% | 1.14% | 0.36% | 0.21% | 0.92% | 0.30% | 0.40% | 0.25% |
| 영업이익률 | 4.26% | 3.41% | 2.87% | 2.85% | 2.05% | 2.96% | 4.43% | 3.18% | 2.78% | 0.85% | 4.13% | 1.22% | 0.32% | 1.70% | 0.88% | 1.07% | 2.45% | 2.99% | 1.83% | 0.64% |
| 순이익률 | 2.65% | 1.90% | 2.70% | 1.03% | 1.95% | 1.89% | 4.19% | 2.40% | 2.34% | 1.58% | 4.45% | 0.41% | 2.11% | 3.28% | 1.08% | 0.56% | 2.50% | 0.91% | 1.19% | 0.72% |
| 매출총이익률 | 20.91% | 20.00% | 19.84% | 19.54% | 19.85% | 19.60% | 20.48% | 20.53% | 19.53% | 18.72% | 19.35% | 18.18% | 16.91% | 18.57% | 17.70% | 17.04% | 18.15% | 19.70% | 18.19% | 17.48% |
| 부채비율 | 67.54% | 67.63% | 59.82% | 67.40% | 66.93% | 70.37% | 71.44% | 75.83% | 77.10% | 83.33% | 82.84% | 87.56% | 91.72% | 89.28% | 88.45% | 90.32% | 93.31% | 85.49% | 85.09% | 85.87% |
| 유동비율 | 181.49% | 180.59% | 196.19% | 180.34% | 181.33% | 171.32% | 172.61% | 154.72% | 161.58% | 145.67% | 147.15% | 138.26% | 140.74% | 155.89% | 154.27% | 153.13% | 141.32% | 136.45% | 129.93% | 134.07% |
| 매출 성장률(YoY) | — | — | — | — | 7.77% | 5.29% | 14.32% | 3.74% | 5.35% | 1.18% | 15.56% | 9.98% | 6.72% | 1.70% | -8.46% | 3.02% | 4.69% | 5.44% | 8.81% | 3.42% |
| 영업이익 성장률(YoY) | — | — | — | — | -48.15% | -8.72% | 76.47% | 15.69% | 43.17% | -71.05% | 7.68% | -57.73% | -87.61% | 104.52% | -80.57% | -9.93% | 692.37% | 85.26% | 127.33% | -37.84% |
| 순이익 성장률(YoY) | — | — | — | — | -20.65% | 4.51% | 77.65% | 140.97% | 26.55% | -15.20% | 22.68% | -81.14% | -3.93% | 110.87% | -77.88% | 41.12% | 24.04% | -70.65% | 20.67% | 32.05% |
| FCF | 229억 | 208억 | -40.41억 | 144억 | 239억 | 32.45억 | -68.23억 | 63.42억 | -246억 | -214억 | -291억 | -301억 | 45.93억 | -333억 | 97.24억 | 139억 | 173억 | 142억 | -130억 | -156억 |
| FCF 마진 | 6.52% | 5.76% | -1.29% | 3.99% | 6.32% | 0.85% | -1.91% | 1.69% | -6.19% | -5.57% | -7.06% | -7.29% | 1.08% | -8.51% | 2.58% | 3.27% | 3.90% | 3.44% | -3.17% | -3.54% |
| CAPEX/매출 | 0.82% | 1.46% | 0.62% | 2.77% | 0.89% | 2.63% | 1.39% | 2.24% | 2.26% | 3.24% | 1.98% | 4.84% | 5.66% | 6.02% | 2.55% | 1.85% | 1.95% | 0.24% | 0.56% | 0.64% |
출처 DART 재무제표 원값으로 자체 계산· 갱신 2026-09-21 07:20· 연결 · 산식은 항목 툴팁